Details for Patent: 8,344,006
Which drugs does patent 8,344,006 protect, and when does it expire?
Patent 8,344,006 protects TREANDA and is included in one NDA.
Protection for TREANDA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has fifteen patent family members in eight countries.
Summary for Patent: 8,344,006
| Title: | Liquid formulations of bendamustine |
| Abstract: | Stable liquid formulations of bendamustine, and pharmaceutically acceptable salts thereof, and polar aprotic solvents, are described. |
| Inventor(s): | Anthony S. Drager, Rachel Y. LaBell, Piyush R. Patel |
| Assignee: | Cephalon LLC |
| Application Number: | US13/362,430 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,344,006 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; |
Drugs Protected by US Patent 8,344,006
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cephalon | TREANDA | bendamustine hydrochloride | SOLUTION;INTRAVENOUS | 022249-003 | Sep 13, 2013 | DISCN | Yes | No | 8,344,006*PED | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| Cephalon | TREANDA | bendamustine hydrochloride | SOLUTION;INTRAVENOUS | 022249-004 | Sep 13, 2013 | DISCN | Yes | No | 8,344,006*PED | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,344,006
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2009296734 | ⤷ Start Trial | |||
| Australia | 2015207940 | ⤷ Start Trial | |||
| Australia | 2016203246 | ⤷ Start Trial | |||
| Australia | 2016247123 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
